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Forty-three patients with juvenile myoclonic epilepsy (JME) is presented. The female to male ratio was 2.9: 1. The patients 
answered a standardized questionnaire pertaining to social situation, medical history, onset of epilepsy, types and frequency 
of seizures, treatment, experienced control over seizures and consequences of having epilepsy. Myoclonic jerks, which are 
the hallmark of the condition, are often forgotten by the patients or not considered as epileptic seizures. This could be one 
reason why JME still seems underdiagnosed. JME may comprise absence, myoclonic and generalized tonic-clonic seizures 
(GTCS), proposed to occur in age-related sequence. We found that absence seizures may start after onset of other seizures. 
Our results confirm the need for medication since, during the last year, only 7% were seizure free without medication. Of 
patients on antiepileptic drugs (AEDs), 79.5% had no GTCS and 41% were seizure free during the last year, which confirms 
a relatively good response to appropriate treatment. Although most patients used AED daily and many still had one or more 
types of epileptic seizure, the epilepsy in general had very little impact on their lives. 
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INTRODUCTION 
Juvenile myoclonic epilepsy (JME) is an idiopathic 
generalized epilepsy. The mean onset is around 
15 years of age, but may vary between 8 and 
26 yearslm3. Juvenile myoclonic epilepsy is charac- 
terized by myoclonic jerks (myoclonic seizures: MS), 
predominantly in the arms. Myoclonic seizures occur 
mostly after awakening. Many patients also have gen- 
eralized tonic-clonic seizures (GTCS), and some have 
absence seizures (AS). The different seizure types 
may occur in an age-related sequence. Interictal and 
ictal EEG is characterized by rapid generalized spike 
waves and polyspike waves. Patients respond well to 
appropriate antiepileptic drugs (AED) therapy, and 
sodium valproate (VPA) is the drug of choice. Ter- 
atogenicity is a topic of special importance, however, 
since many young women are affected. 
Juvenile myoclonic epilepsy still seems underdiag- 
nosed, although the syndrome is well characterized, 
and accounts for 5-l 1% of the adult epileptic pop- 
ulation’. Diagnosis is often delayed due to insuffi- 
cient knowledge of the syndrome2,4-6. Variation in 
prevalence may reflect variation in diagnostic criteria, 
or undiagnosed patients. The development of seizure 
types and long-term prognosis in patients are uncer- 
tain, and consequently the indication for discontinu- 
ation of medication. 
There is general agreement that the disease is ge- 
netically determined. Different modes of inheritance 
have been proposed. Reports7-’ ’ indicate linkage to 
the HLA-region of chromosome 6p of a locus pre- 
disposing to JME. Subsequent studies do not confirm 
this and propose genetic heterogeneity or compound 
influence of the EJM-1 and other genes12-“. 
Linkage to the HLA region and genetic heterogene- 
ity makes it important to study JME in different pop- 
ulations. The possibility of enhanced heterogeneity 
in epilepsy populations with great variation in onset 
prompted us to characterize a homogeneous group 
of JME patients with respect to seizures, medication, 
psychosocial aspects and prognosis. 
PATIENTS AND METHODS 
Patients 
Medical records of 65 epilepsy patients registered 
with possible JME and attending the Neurological 
Department at Haukeland University Hospital were 
studied. Since no established dejinition of JME exists, 
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despite clinical description”, we used the following 
diagnostic criteria for this study. Certain JME: my- 
oclonic jerks, f GTC or absences; onset 15 f4 years; 
EEG: bilateral polyspike waves. Probable JME: my- 
oclonic jerks, +GTK or absences; onset 15 f 7 years; 
EEG: bilateral epileptic activity. Common criteria: no 
evidence of head trauma, encephalitis or degenerative 
disease as a causative factor, no evidence of men- 
tal retardation; slight or infrequent EEG asymmetries 
were not considered as exclusion criteria16T 17. 
The diagnosis of JME was judged to be certain or 
probable in 49 cases. All were asked to participate, 
but four did not show up. Forty-five patients were in- 
terviewed, and the questionnaire was returned by 43. 
The questionnaire 
The patients were asked to answer a standardized 
questionnaire about the following subjects: social sit- 
uation; family and own medical history; onset of 
epilepsy; types and frequency of seizures; provoca- 
tional factors and treatment. The patients were, for 
instance, asked to confirm or deny the presence of 
a seizure type. In addition, the patients were asked 
about feeling of control over seizures and conse- 
quences of having epilepsy. These latter questions 
had graded answers, i.e. the patients were asked to 
mark one of seven boxes describing the answers from, 
for instance, ‘Not at all’ (score: 1) to ‘High degree’ 
(score: 7). 
RESULTS 
Patients 
Forty-three patients returned the questionnaire (96%), 
32 women and 11 men. Of these 21 patients had cer- 
tain and 22 probable JME. In the group of probable 
JME we included a male patient with anamnestic my- 
oclonic status epilepticus with loss of consciousness 
and interictal bilateral epileptic activity in EEG, in 
spite of no observed polyspikes. Duration of treat- 
ment varied from l-39 years. The mean age of the 
patients was 29 f 9 (SD) years (range 17-57 years). 
Twenty-one were single, twelve married, eight liv- 
ing with steady partners and two divorced. Sixteen 
patients had children. Fifteen patients had higher ed- 
ucation and eleven were students. Twenty-four were 
employed, one was unemployed, three had social in- 
surance, one was a housewife, and three gave no in- 
formation regarding employment. 
The proportion of patients with higher education, 
i.e. university or post-high-school education, was 
slightly higher than expected. According to the offi- 
cial statistics in Norway, the proportion of people 16- 
60 years with higher education in our county (Horda- 
land) is 20.6%. In our material 15 (34.9%) had higher 
education. The populations may not be directly com- 
parable, however, because of the difference in age 
distribution. Exact figures are not available, but the 
educational status in the JME population may corre- 
spond to a normal distribution when compared to the 
mean age. 
Family history 
Twelve patients (28%), nine female and three male, 
had a positive family history of epilepsy. Six had 
certain JME and six probable JME. Eight patients re- 
ported epilepsy in close relatives, i.e. three in sisters, 
three in mothers, one in a brother and one in the fa- 
ther. Four reported epilepsy in distant relatives. Nine- 
teen had relatives with allergy, seven with asthma, 
eleven with rheumatoid arthritis, ten with diabetes 
mellitus, eight with myocardial infarct/stroke before 
60 years of age, and six with other neurological dis- 
eases. 
Own medical history 
Febrile convulsions in infancy had occurred in four 
patients. Four had a history of psychiatric symptoms, 
i.e. anxiety, claustrophobia, depression. One had at- 
tempted suicide. Nine patients had pollen allergy, 
nine excema, ten other types of allergy and three had 
asthma. None had diabetes mellitus, systemic lupns 
erythematosus (SLE) or other neurological diseases. 
Seizure onset 
The patients reported an age at seizure onset of 15 f 
2.8 years (mean f SD) corresponding to initial inclu- 
sion criteria. The age at diagnosis was 16f4.1 years. 
Most (n = 32) of the patients reported GTCS as their 
first seizure, nine MS, one AS and one a combina- 
tion of MS and AS (Fig. 1). Ten patients reported 
AS after GTCS as first seizure, and two after MS 
as first seizure. We were of course not able to docu- 
ment classical absences in this study, as most of the 
information derives from the questionnaire. 
The first seizure was often precipitated by sleep 
deprivation (n = 21), eight of them in combination 
with alcohol intake. One had the first seizure dur- 
ing a febrile illness. Fifteen patients reported the first 
seizure related to stress, ten to puberty, five to ‘family 
crisis’, and five to head trauma. 
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Fig. 1: First seizure as reported by patients. 
Seizure types 
Thirty-seven patients reported having one or more 
GTCS and 14 reported AS (one with ‘automatismus’, 
not known from medical records). Only 35 patients 
reported MS as a seizure type, in spite of this be- 
ing an inclusion criterion. On specific request, all pa- 
tients had confirmed at least once the presence of 
myoclonies following awakening or during the day 
in accordance with medical records. In Fig. 2, there- 
fore, all are supposed to have had MS. 
Fig. 2: Types of seizures reported by patients. 
According to the questionnaire five patients had 
MS only, 24 had MS and GTCS, 13 had MS, GTCS 
and AS, and one had MS and AS (Fig. 2). According 
to the medical records, three had MS only (7%), 29 
had MS and GTCS (67%) and 11 had MS, GTCS 
and AS (26%). 
There is some discrepancy between the medical 
records and seizures reported by patients in the ques- 
tionnaire. Three female patients reported AS which 
were previously unknown to us. Three patients who 
had had only one GTCS answered negatively to the 
question ‘Have you had GTCS?’ One of them de- 
nied GTCS, but confirmed AS. One patient denied 
AS, which were thoroughly described in his medical 
records. Seven patients had had only one GTCS since 
onset. 
Seizure warning signals and postictal 
phenomena 
Concerning characterization of their seizures, 28 con- 
sidered GTCS as their ‘typical’ seizure, eight AS and 
seven MS. Sixteen patients reported the GTCS to be 
preceded by a warning signal, either every time or 
occasionally. Most often this was myoclonic jerks. 
Some patients had scattered myoclonies for hours pre- 
ceding GTCS. One patient with only MS reported a 
warning signal with ‘a special feeling inside the head’ 
before the start of myoclonies. One patient had sev- 
eral sudden falls because of myoclonies in the legs be- 
fore GTCS. Examples of other warning signals were 
feelings of numbness, restlessness, tremor or anxiety 
of short duration. One patient described a feeling of 
pressure in the head and ‘a feeling of being outside 
her body’ before the start of myoclonies in conjunc- 
tion with AS which occurred in series, lasting up to 
half an hour. 
After GTCS, most patients experienced confusion, 
fatigue and postictal sleep. Many also complained 
about headache. Four patients had nausea, and three 
described anxiety, restlessness or nervousness. In ad- 
dition, three described a feeling of strong depression, 
despair or even guilt. This was explained further as 
‘regretting involving other people’ or ‘I totally lossed 
control’. 
Provocational factors 
Sleep deprivation was the most conspicuous factor 
(Fig. 3) reported in 36 patients. Two patients did not 
answer. 
Present medication and seizure situation during 
the last year 
Thirty-nine patients used AED (90.7% of all). Of 
these, 31 (79.5%) used VPA alone or in combi- 
nation with daily doses of 450-2100 mg. VPA as 
monotherapy was used by 25 (450-1500 mg daily). 
Four used VPA in combination with one AED (two 
carbamazepin, two clonazepam) and two used VPA in 
combination with two other AED. Clonazepam mono- 
therapy was used by three (0.5-5 mg daily), pheny- 
toin monotherapy by three (200-350 mg daily) and 
carbamazepin monotherapy by two (400 and 600 mg). 
All patients used AED for some time, but four were 
presently without treatment. Six of the 43 patients 
had never tried VPA. In total, 35 of the 43 patients 
(81.4%) had no GTCS during the last year. Twenty- 
eight patients (65.1%) had neither GTCS nor AS, and 
19 patients (44.2%) were completely free of seizures 
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Changed sleeping habits 
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Fig. 3: Provocational factors reported by patients. 
during the last year. Side effects 
Of those with seizures in the last year eight had 
one or more GTCS, nine one or more AS, and 21 MS. 
The combination of seizures were as follows (Fig. 4): 
MS only in nine (38% of 24 patients), GTCS only in 
two, AS only in one. Four had GTCS + MS, six had 
AS + MS and two had GTCS + MS + AS. 
The following side effects were reported (Fig. 5), re- 
gardless of the specific AED treatment. The most un- 
pleasant side effects were reported to be weight gain, 
fatigue, concentration difficulties and depression. 
Fig. 4: Seizures reported in 24 patients, with seizures in the 
last year. 
Of the 19 seizure-free patients, three had no med- 
ication. Two patients had been seizure free for more 
than 10 years, eight for 5-10 years, and nine for less 
than 5 years. Among the 39 patients with AED treat- 
ment, 16 (41.0%) were seizure free and all of them 
were on monotherapy, of which 13 had VPA. One 
patient without AED reported more than 1OMS + AS 
during the last year. She preferred to regulate her 
lifestyle with reduced working hours, etc. She an- 
swered with a score of 5 to the question about control 
over seizure frequency. The two patients on carba- 
mazepin monotherapy still had MS, but no GTCS or 
AS. 
20 
Number 
Patients’ impression of seizure control 
The question ‘Do you feel that you have control 
over the frequency of seizures?’ had graded answers 
from ‘Not at all’ (Score: 1) to ‘Very high control’ 
(Score: 7). Two patients did not answer (Fig. 6). The 
patients that felt a considerate degree of control, men- 
tioned regulation factors such as: avoiding alcohol, 
stress and music videos, getting enough sleep, taking 
their medication regularly, reduced working hours, 
etc. 
Duration of epilepsy had no obvious impact on 
these answers. Of 10 patients with l-3.5 years since 
diagnosis, six reported a degree of control scoring 
4-7. Of 10 patients with more than 20 years since 
diagnosis, seven reported a degree of control scoring 
4-7. 
To find out whether seizure frequency had any im- 
pact on the same question, the patients were divided 
in two groups, according to whether they had had any 
seizures during the last year or not. Interestingly, pa- 
tients with seizures tended to report a higher degree 
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Fig. 5: Side effects reported by patients. 
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Fig. 6: Experienced control over seizure frequency. 
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Fig. 7: Control over the frequency of seizure, with or without seizures the last year. 
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of control, or feeling of control, than patients without 
seizures (Fig. 7). 
The question about control over the course of a 
seizure was similarly designed (Fig. 8). Of 10 pa- 
tients with a feeling of control scoring 4-7, six ex- 
perienced GTCS preceded by warning factors. When 
they got the warning, they tried to relax, eat some- 
thing, breathe deeply or take diazepam. 
1 2 3 4 5 6 7 0 
1: Not at all, 7: High degree, 0: Unanswered 
Fig. 8: Experienced control over the course of seizures. 
Questions concerning the quality of life 
The patents were presented questions pertaining to 
the impact of their epilepsy on socioeconomic, fa- 
milial and private aspects of life. The purpose was 
not a complete psychosocial mapping however, since 
a group of the patients previously had replied to 
the Washington Psychosocial Inventory (WPSI). Most 
questions allowed graded answers as described in 
Figs 6-8. In general, patients reported little impact 
of their epilepsy on the quality of life and only a few 
answers are reported below. 
Fig. 9: How do you characterize your epilepsy? 
Of the three patients that answered ‘Very annoy- 
ing’, two had been seizure-free for the last year, and 
one had only MS. The six patients that answered ‘An- 
noying’, had all had at least two types of seizures dur- 
ing the last year. Obviously the frequency of seizures 
is a factor contributing to the burden of epilepsy, but 
not the only one. 
Figures 10 and 11 were included since the ques- 
tions pertain to slightly different aspects, i.e. quality 
vs. absence. The four patients who answered with 
scores of 5-7 all had at least two seizure types dur- 
ing the last year. The three patients who reported ab- 
sence from work of greater than 4 weeks had social 
insurance. The patients with frequent absence from 
work/studies generally had at least two seizure types 
during the last year. The impact of the epilepsy on 
social activities is generally low, as shown in Fig. 12. 
Questions concerning the impact of the epilepsy on 
family life were answered with an almost identical 
profile (not shown) as in Fig. 12. 
1 2 3 4 5 6 7 0 
1: Not at all. 7: High degree, 0: Unanswered 
Fig. IO: Does your epilepsy affect your work/studies? 
l-5 days 
Fig. 11: Absence from work/studies because of epilepsy. 
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1: Not at all, 7: High degree, 0: Unanswered 
Fig. 12: How often do you have to cancel social activities 
because of your epilepsy? 
As a general statement, and support to the answers 
concerning social activity and family life we have in- 
cluded the profile of answers concerning the overall 
situation at present (Fig. 13). 
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1: Not at all. 7: High degree, 0: Unanswered 
Fig. 13: Are you satisfied with your life right now? 
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DISCUSSION 
An equal distribution between sexes has been claimed 
for JME1,3. In our population there is a marked fe- 
male predominance, the reason for which is unclear. 
The seizure threshold in patients with idiopathic gen- 
eralized epilepsy may be lower in women than men’ 
which could explain a female predominance in JME 
as suggested in other studies18-2”. Alternatively, we 
have missed the diagnosis in male patients. Another 
explanation is that we examined an unselected group 
of patients, in contrast to studies of patients with un- 
controlled epilepsy4. If this assumption is correct, one 
might assume better prognosis for female than male 
JME patients. 
A tentative explanation for female predominance 
was presented in a panel discussion2’ as an overrep- 
resentation of female patients with photic sensitiv- 
ity including myoclonic jerks and occasional GTCS. 
These patients were classified as an overlap group 
that did not belong in the JME classification. With our 
current, strict criteria, any overlap group is not plausi- 
ble. The criteria were actually established to minimize 
possible overlap or variability due to a large varia- 
tion in onset age of epilepsy”. The latter publication 
revealed increased incidence of epilepsy in near rel- 
atives of female JME patients, than in those of male 
JME patients 19. Our study sugg ests that epilepsy may 
be more common in female than in male relatives. 
Another observation in our study is that AS may 
start after initial MS or GTCS, which is at variance 
with other investigations”‘.5122. The different seizure 
types in JME may occur in age-related sequence, and 
AS is reported never to precede GTCS or MS2?. Our 
findings corroborate that of another recent Scandina- 
vian investigation2’. In 10 patients AS occurred after 
GTCS as the first seizure, and in two patients after 
MS as the first seizure. 
Three female patients reported AS in addition to 
their known seizure type. Two of them described 
seizures in a way suggesting that the absences might 
be forceful myoclonies with a feeling of brief loss of 
consciousness. Moreover, AS in JME may be mild 
and go unnoticed6. Nevertheless, seizure types were 
clearly defined for the patients, and in few instances 
AS were observed clinically and during EEG regis- 
tration. 
The discrepancy between seizures reported in med- 
ical records and questionnaires needs further com- 
ment. Myoclonies are often overlooked by patients or 
physicians, and their diagnosis will often depend on 
specific questioning6. Even after confirmation of my- 
oclinic jerks, some patients obviously do not consider 
them as seizures and consequently do not report them. 
Furthermore, use of a standardized questionnaire may 
be compatible with a semistructured interview, which 
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may be less sensitive for generalized than for partial 
seizures23. 
Concerning the prognosis. 19 of 43 patients 
(44.2%) were completely seizure free during the last 
year, whereas 3.5 (8 1.4%) had no GTCS. This is not 
impressing, since reports suggest that VPA controls 
seizures in approximately 80%2. However, our find- 
ings closely corroborate that of a recent Swedish 
study . 2o Only three patients (7%) were seizure free 
without medication, which is consistent with the re- 
ported relapse rate of over 90% following with- 
drawal 1.4.24 
Reports concerning experienced control over fre- 
quency and course of seizures referred to either warn- 
ing signs or knowledge of specific triggering factors. 
Patients with seizures during the last year tended 
to report a higher degree of control over seizure 
frequency than patients who were seizure free. We 
cannot exclude an artefact in the sense no seizures: 
no control. Control over the course of seizures was 
mainly related to different warning signs. 
In conclusion our clinical data confirm that Nor- 
wegian patients are comparable to those of other eth- 
nic groups with JME, supporting the homogeneity of 
the JME syndrome. Despite the continuous need for 
medication, the prognosis in other aspects is quite 
favourable. The GTCS are well controlled for most 
of the patients, and the impact of the epilepsy on their 
daily lives is small for the great majority. 
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